| Gregory P Samano Ii, DO | |
|
499 E Central Pkwy, Altamonte Springs, FL 32701-3449 | |
| (407) 543-3461 | |
| (407) 678-0627 |
| Full Name | Gregory P Samano Ii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 499 E Central Pkwy, Altamonte Springs, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205804226 | NPI | - | NPPES |
| 47244 | Other | FL | BC BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 057764 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vmd Primary Providers Central Florida Pllc | 2860806197 | 116 |
News Archive
Partners from Austria – represented by Medical University of Vienna – Germany, France and the Netherlands are taking part in the EU "MOON" project (multimodal optical diagnostics for age-related diseases of the eye and central nervous system) to develop new techniques for early diagnosis of these diseases and successfully apply them in treatment and diagnosis.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Everybody feels pain differently, and brain structure may hold the clue to these differences. In a study published in the current online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center have shown that the brain's structure is related to how intensely people perceive pain.
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
› Verified 9 days ago
| Entity Name | Family Medical Care Of Mount Dora Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265844757 PECOS PAC ID: 3274859632 Enrollment ID: O20150302000684 |
News Archive
Partners from Austria – represented by Medical University of Vienna – Germany, France and the Netherlands are taking part in the EU "MOON" project (multimodal optical diagnostics for age-related diseases of the eye and central nervous system) to develop new techniques for early diagnosis of these diseases and successfully apply them in treatment and diagnosis.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Everybody feels pain differently, and brain structure may hold the clue to these differences. In a study published in the current online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center have shown that the brain's structure is related to how intensely people perceive pain.
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
› Verified 9 days ago
| Entity Name | Vmd Primary Providers Central Florida Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134738974 PECOS PAC ID: 2860806197 Enrollment ID: O20210128001072 |
News Archive
Partners from Austria – represented by Medical University of Vienna – Germany, France and the Netherlands are taking part in the EU "MOON" project (multimodal optical diagnostics for age-related diseases of the eye and central nervous system) to develop new techniques for early diagnosis of these diseases and successfully apply them in treatment and diagnosis.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Everybody feels pain differently, and brain structure may hold the clue to these differences. In a study published in the current online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center have shown that the brain's structure is related to how intensely people perceive pain.
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory P Samano Ii, DO 499 E Central Pkwy, Altamonte Springs, FL 32701-3449 Ph: (407) 543-3461 | Gregory P Samano Ii, DO 499 E Central Pkwy, Altamonte Springs, FL 32701-3449 Ph: (407) 543-3461 |
News Archive
Partners from Austria – represented by Medical University of Vienna – Germany, France and the Netherlands are taking part in the EU "MOON" project (multimodal optical diagnostics for age-related diseases of the eye and central nervous system) to develop new techniques for early diagnosis of these diseases and successfully apply them in treatment and diagnosis.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Everybody feels pain differently, and brain structure may hold the clue to these differences. In a study published in the current online issue of the journal Pain, scientists at Wake Forest Baptist Medical Center have shown that the brain's structure is related to how intensely people perceive pain.
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
Eli Lilly and Company announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) - due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.
› Verified 9 days ago
Dr. Carol Andrea Stewart, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 N Westmonte Dr Ste 1000, Altamonte Springs, FL 32714 Phone: 407-862-4500 Fax: 407-862-1173 | |
Andrew E Krupitsky, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 249 Maitland Ave, Suite 1000, Altamonte Springs, FL 32701 Phone: 407-332-6366 Fax: 407-830-4300 | |
Dr. Fior D Rojas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 Douglas Ave, Altamonte Springs, FL 32714 Phone: 407-788-8200 Fax: 407-788-3746 | |
Dr. Ashton Chase Brinson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 695 Douglas Ave, Altamonte Springs, FL 32714 Phone: 407-774-7080 Fax: 407-774-7090 | |
Dr. Scott William Vanlue, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 940 Centre Cir, Suite 1010, Altamonte Springs, FL 32714 Phone: 407-862-5637 | |
Shashi Yuvraj Yoganand, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 303 E Altamonte Dr Ste 1000, Altamonte Springs, FL 32701 Phone: 407-349-7917 Fax: 407-205-1060 |